Integer Holdings Corporation (NYSE:ITGR) Receives Consensus Recommendation of “Hold” from Brokerages

Shares of Integer Holdings Corporation (NYSE:ITGR) have been given a consensus recommendation of “Hold” by the fourteen ratings firms that are covering the company, Marketbeat reports. Thirteen analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average 12 month price objective among brokerages that have issued a report on the stock in the last year is $109.8571.

Several equities analysts have weighed in on ITGR shares. Benchmark cut shares of Integer from a “buy” rating to a “hold” rating in a research report on Thursday, August 13th. HC Wainwright restated a “buy” rating on shares of Integer in a report on Friday, July 24th. Truist Financial cut Integer from a “buy” rating to a “hold” rating and raised their target price for the stock from $110.00 to $127.00 in a research report on Monday, August 3rd. Citigroup lifted their price target on Integer from $92.00 to $96.00 and gave the company a “neutral” rating in a report on Wednesday, July 8th. Finally, Piper Sandler lowered Integer from an “overweight” rating to a “hold” rating and set a $127.00 price target on the stock. in a research report on Monday, August 3rd.

Integer Stock Performance

Integer stock opened at $125.22 on Wednesday. The firm’s 50 day simple moving average is $104.12 and its 200-day simple moving average is $93.15. The company has a market cap of $4.26 billion, a P/E ratio of 34.21, a price-to-earnings-growth ratio of 2.96 and a beta of 0.61. The company has a debt-to-equity ratio of 0.75, a current ratio of 3.73 and a quick ratio of 2.41. Integer has a fifty-two week low of $62.00 and a fifty-two week high of $126.14.

Integer (NYSE:ITGR) last released its quarterly earnings results on Monday, August 3rd. The medical equipment provider reported $1.60 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.38 by $0.22. The business had revenue of $464.11 million for the quarter, compared to analyst estimates of $451.07 million. Integer had a net margin of 6.97% and a return on equity of 12.79%. The firm’s revenue was down 2.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.55 earnings per share. As a group, equities research analysts predict that Integer will post 6.08 EPS for the current year.

Hedge Funds Weigh In On Integer

Several institutional investors and hedge funds have recently bought and sold shares of ITGR. Heartland Advisors Inc. grew its stake in Integer by 506.8% in the fourth quarter. Heartland Advisors Inc. now owns 242,715 shares of the medical equipment provider’s stock valued at $19,036,000 after purchasing an additional 202,715 shares in the last quarter. WINTON GROUP Ltd acquired a new position in Integer in the 4th quarter worth about $4,836,000. Jennison Associates LLC acquired a new position in Integer in the 4th quarter worth about $1,036,000. Kestrel Investment Management Corp purchased a new stake in shares of Integer during the 4th quarter worth about $5,933,000. Finally, William Blair Investment Management LLC raised its stake in shares of Integer by 70.1% during the 4th quarter. William Blair Investment Management LLC now owns 468,377 shares of the medical equipment provider’s stock worth $36,735,000 after purchasing an additional 192,956 shares in the last quarter. Hedge funds and other institutional investors own 99.29% of the company’s stock.

About Integer

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.